Recommendations

110
Smith et al. 2005
ACC/AHA/SCAI Practice Guidelines
ACC - www.acc.org
AHA - www.americanheart.org
SCAI - www.scai.org
angioplasty of a stenosis at the origin of the left internal mammary
artery graft: a case report. Cathet Cardiovasc Diagn 1988;15:
176-8.
543. Sketch MHJ, Quigley PJ, Perez JA, et al. Angiographic follow-up
after internal mammary artery graft angioplasty. Am J Cardiol
1992;70:401-3.
544. Popma JJ, Cooke RH, Leon MB, et al. Immediate procedural and
long-term clinical results of internal mammary artery angioplasty.
Am J Cardiol 1992;69:1237-9.
545. Pijls NH, van Son JA, Kirkeeide RL, De Bruyne B, Gould KL.
Experimental basis of determining maximum coronary, myocardial,
and collateral blood flow by pressure measurements for
assessing functional stenosis severity before and after percutaneous
transluminal coronary angioplasty. Circulation 1993;87:
1354-67.
546. Breall JA, Grossman W, Stillman IE, Gianturco LE, Kim D.
Atherectomy of the subclavian artery for patients with symptomatic
coronary-subclavian steal syndrome. J Am Coll Cardiol
1993;21:1564-7.
547. Perrault LP, Carrier M, Hudon G, Lemarbre L, Hebert Y, Pelletier
LC. Transluminal angioplasty of the subclavian artery in patients
with internal mammary grafts. Ann Thorac Surg 1993;56:927-30.
548. Tan KH, Henderson RA, Sulke N, Cooke RA, Karani S, Sowton
E. Percutaneous transluminal coronary angioplasty in patients
with prior coronary artery bypass grafting: ten years’ experience.
Cathet Cardiovasc Diagn 1994;32:11-7.
549. Abbo KM, Dooris M, Glazier S, et al. Features and outcome of
no-reflow after percutaneous coronary intervention. Am J Cardiol
1995;75:778-82.
550. Liu MW, Douglas JSJ, Lembo NJ, King SB3. Angiographic predictors
of a rise in serum creatine kinase (distal embolization)
after balloon angioplasty of saphenous vein coronary artery
bypass grafts. Am J Cardiol 1993;72:514-7.
551. Meany TB, Leon MB, Kramer BL, et al. Transluminal extraction
catheter for the treatment of diseased saphenous vein grafts: a
multicenter experience. Cathet Cardiovasc Diagn 1995;34:112-20.
552. Safian RD, Grines CL, May MA, et al. Clinical and angiographic
results of transluminal extraction coronary atherectomy in saphenous
vein bypass grafts. Circulation 1994;89:302-12.
553. Dooris M, Hoffmann M, Glazier S, et al. Comparative results of
transluminal extraction coronary atherectomy in saphenous vein
graft lesions with and without thrombus. J Am Coll Cardiol
1995;25:1700-5.
554. Kaplan BM, Safian RD, Grines CL, et al. Usefulness of adjunctive
angioscopy and extraction atherectomy before stent implantation
in high-risk aortocoronary saphenous vein grafts. Am J
Cardiol 1995;76:822-4.
555. Hong MK, Popma JJ, Pichard AD, et al. Clinical significance of
distal embolization after transluminal extraction atherectomy in
diffusely diseased saphenous vein grafts. Am Heart J 1994;127:
1496-503.
556. Barcin C, Denktas AE, Lennon RJ, et al. Comparison of combination
therapy of adenosine and nitroprusside with adenosine
alone in the treatment of angiographic no-reflow phenomenon.
Catheter Cardiovasc Interv 2004;61:484-91.
557. Parham WA, Bouhasin A, Ciaramita JP, Khoukaz S, Herrmann
SC, Kern MJ. Coronary hyperemic dose responses of intracoronary
sodium nitroprusside. Circulation 2004;109:1236-43.
558. Hillegass WB, Dean NA, Liao L, Rhinehart RG, Myers PR.
Treatment of no-reflow and impaired flow with the nitric oxide
donor nitroprusside following percutaneous coronary interventions:
initial human clinical experience. J Am Coll Cardiol
2001;37:1335-43.
559. Weyrens FJ, Mooney J, Lesser J, Mooney MR. Intracoronary diltiazem
for microvascular spasm after interventional therapy. Am J
Cardiol 1995;75:849-50.
560. Stephan WJ, Bates ER, Garratt KN, Hinohara T, Muller DW.
Directional atherectomy of coronary and saphenous vein graft
ostial stenoses. Am J Cardiol 1995;75:1015-8.
561. Cowley MJ, Whitlow PL, Baim DS, Hinohara T, Hall K, Simpson
JB. Directional coronary atherectomy of saphenous vein graft narrowings:
multicenter investigational experience. Am J Cardiol
1993;72:30E-4E.
562. Savage MP, Douglas JSJ, Fischman DL, et al. Stent placement
compared with balloon angioplasty for obstructed coronary
bypass grafts: Saphenous Vein De Novo Trial Investigators. N
Engl J Med 1997;337:740-7.
563. Abdelmeguid AE, Whitlow PL, Simpfendorfer C, et al.
Percutaneous revascularization of ostial saphenous vein graft
stenoses. J Am Coll Cardiol 1995;26:955-60.
564. Rechavia E, Litvack F, Macko G, Eigler NL. Stent implantation of
saphenous vein graft aorto-ostial lesions in patients with unstable
ischemic syndromes: immediate angiographic results and longterm
clinical outcome. J Am Coll Cardiol 1995;25:866-70.
565. Wong SC, Popma JJ, Pichard AD, et al. Comparison of clinical
and angiographic outcomes after saphenous vein graft angioplasty
using coronary versus ‘biliary’ tubular slotted stents.
Circulation 1995;91:339-50.
566. Eeckhout E, Goy JJ, Stauffer JC, Vogt P, Kappenberger L.
Endoluminal stenting of narrowed saphenous vein grafts: longterm
clinical and angiographic follow-up. Cathet Cardiovasc
Diagn 1994;32:139-46.
567. Keane D, Buis B, Reifart N, et al. Clinical and angiographic outcome
following implantation of the new Less Shortening Wallstent
in aortocoronary vein grafts: introduction of a second generation
stent in the clinical arena. J Interv Cardiol 1994;7:557-64.
568. Fenton SH, Fischman DL, Savage MP, et al. Long-term angiographic
and clinical outcome after implantation of balloonexpandable
stents in aortocoronary saphenous vein grafts. Am J
Cardiol 1994;74:1187-91.
569. Piana RN, Moscucci M, Cohen DJ, et al. Palmaz-Schatz stenting
for treatment of focal vein graft stenosis: immediate results and
long-term outcome. J Am Coll Cardiol 1994;23:1296-304.
570. Ellis SG, Brener SJ, DeLuca S, et al. Late myocardial ischemic
events after saphenous vein graft intervention--importance of initially
“nonsignificant” vein graft lesions. Am J Cardiol
1997;79:1460-4.
571. de Jaegere P, van Domburg RT, Feyter PJ, et al. Long-term clinical
outcome after stent implantation in saphenous vein grafts. J
Am Coll Cardiol 1996;28:89-96.
572. Kahn JK, Rutherford BD, McConahay DR, et al. Initial and longterm
outcome of 83 patients after balloon angioplasty of totally
occluded bypass grafts. J Am Coll Cardiol 1994;23:1038-42.
573. Hartmann JR, McKeever LS, Stamato NJ, et al. Recanalization of
chronically occluded aortocoronary saphenous vein bypass grafts
by extended infusion of urokinase: initial results and short-term
clinical follow-up. J Am Coll Cardiol 1991;18:1517-23.
574. Hartmann JR, McKeever LS, O’Neill WW, et al. Recanalization
of Chronically Occluded Aortocoronary Saphenous Vein Bypass
Grafts With Long-Term, Low Dose Direct Infusion of Urokinase
(ROBUST): a serial trial. J Am Coll Cardiol 1996;27:60-6.
575. Denardo SJ, Morris NB, Rocha-Singh KJ, Curtis GP, Rubenson
DS, Teirstein PS. Safety and efficacy of extended urokinase infusion
plus stent deployment for treatment of obstructed, older